TLDR Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.
In a 2016 study involving 109 ethnic Chinese women with polycystic ovary syndrome (PCOS), metformin was found to significantly improve health-related quality of life (HRQOL), particularly in the physical domain of WHOQOL-Bref and in aspects of PCOS-specific HRQOL such as infertility, acne, and hair loss. The improvements were most notable in overweight (56% of participants) and hyperandrogenic (80% of participants) subgroups. Psychological disturbances related to these symptoms were also significantly ameliorated by metformin, especially in the aforementioned subgroups. Although the emotions domain of HRQOL improved, this change was not statistically significant. The study suggests that metformin may enhance HRQOL in women with PCOS by improving symptoms like acne and hair loss, which are often associated with hyperandrogenism.View this study on hqlo.biomedcentral.com →
Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.
The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.
Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.
Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.
The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.
Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.